The Human Genome Project solves mystery diseases

By Admin
Written by Alyssa Clark Neurological problems, mystery adult illnesses, mental slowness or unexplainable muscle weakness— these are all problems...

Written by Alyssa Clark

Neurological problems, mystery adult illnesses, mental slowness or unexplainable muscle weakness— these are all problems plaguing today’s people, with no cause or solution in sight. Adults and children alike experience strange symptoms whether it be neurologically or physically, but now scientists are suggesting a possible crack in the code when determining the cause of these mystery illnesses. The solution: an analysis of a person’s genetic makeup.

"Many of these are children or adults that have had a mystery illness for many years. Their families don't know what it is and they're sort of desperate for an answer," and it's not possible to find a treatment until you find the cause, he said.

This study is breaking ground as the first of its kind, in a large scale effort to move gene sequencing out of the laboratory and into the everyday practice of medical care— hopes are set pretty high that this technology will pay off.

"This is a direct benefit of the Human Genome Project," the big effort to decode our DNA, said Dr. Christine M. Eng of Baylor College of Medicine in Houston. "We're now able to directly benefit patients through more accurate diagnosis."

The study was published last Wednesday online, in the New England Journal of Medicine with Dr. Eng leading the study. The most recent results show a survey of the 250 patients who were referred to Dr. Eng for her work in a newer type of sequencing (DNA segments which hold the recipes for all the body needs). This type of analysis only accounts for 1 percent of the entire human genome. A total of 1,700 patients have undergone the study so far at Baylor, as they have branched out in testing more patients outside of the study. Eng reported that genome flaws were found in 1 out of 4 people tested.

As more genes are linked to diseases, the diagnoses rate will go us. It already is much higher than it has been in the past, due to the complexity and thorough workings of the genome test.

"For some of these conditions there could be treatments that are lifesaving," said Rebecca Nagy, a scientist at Ohio State University and president of the National Society of Genetic Counselors.

In the initial study of analyzing genes in order to diagnose mystery illnesses of the 2250 patients, 62 of them were found to have genetic flaws. In 33 of those specific cases, only one faulty copy of a gene was responsible. In all 16 other cases, both copies of the gene were bad. Four patients had problems in two different genes, and nine patients had faulty genes on the X chromosome, which spoke to a connection between the faulty genes and men.

 

About the Author

Alyssa Clark is the Editor of Healthcare Global

Share
Share

Featured Articles

Tata Consultancy Report Shows AI in Healthcare on Rise

Tata Consultancy Services AI for Business Global Study shows that three-quarters of healthcare leaders are deploying AI to drive innovation and efficiency

McKinsey: Consumers Demand Data-driven Wellness Products

New McKinsey Future of Wellness survey shows that consumers demand data-driven wellness solutions to improve health, sleep, nutrition, fitness & longevity

SpaceX Starlink Launch Boost for Indonesia Healthcare

As SpaceX CEO Elon Musk helps launch new satellite in Indonesia, we look at how the Starlink programme is improving healthcare provision in remote areas

J&J Targets Supplier Sustainability to Cut Healthcare GHGs

Sustainability

Walgreens to Sell Over-the-Counter Opioid Overdose Drug

Medical Devices & Pharma

McKinsey Health Institute: Focus on Health Insights Body

Digital Healthcare